Inventor
HURME REINI
FI18 patents
⚠️ This page may combine multiple inventors who share the name “HURME REINI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZORA BIOSCIENCES OY
14 patentsUS12025623B2Jul 2, 2024
Lipidomic biomarkers for atherosclerosis and cardiovascular disease
ZORA BIOSCIENCES OY2 citations71
US10551394B2Feb 4, 2020
Lipidomic biomarkers for atherosclerosis and cardiovascular disease
ZORA BIOSCIENCES OY2 citations71
US12270816B2Apr 8, 2025
Lipidomic biomarkers for identification of high-risk coronary artery disease patients
ZORA BIOSCIENCES OY0 citations61
US10955427B2Mar 23, 2021
Lipidomic biomarkers for identification of high-risk coronary artery disease patients
ZORA BIOSCIENCES OY0 citations61
US9052328B2Jun 9, 2015
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
ZORA BIOSCIENCES OY1 citations59
US10261101B2Apr 16, 2019
Lipidomic biomarkers for identification of high-risk coronary artery disease patients
ZORA BIOSCIENCES OY0 citations51
US9863965B2Jan 9, 2018
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
ZORA BIOSCIENCES OY0 citations51
US9857386B2Jan 2, 2018
Lipidomic biomarkers for atherosclerosis and cardiovascular disease
ZORA BIOSCIENCES OY0 citations51
US9841431B2Dec 12, 2017
Lipidomic biomarkers for identification of high-risk coronary artery disease patients
ZORA BIOSCIENCES OY0 citations51
US9459265B2Oct 4, 2016
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
ZORA BIOSCIENCES OY0 citations51
US9423406B2Aug 23, 2016
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
ZORA BIOSCIENCES OY0 citations51
US9052327B2Jun 9, 2015
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
ZORA BIOSCIENCES OY1 citations49
US9459264B2Oct 4, 2016
Lipidomic biomarkers for atherosclerosis and cardiovascular disease
ZORA BIOSCIENCES OY0 citations48
US10184932B2Jan 22, 2019
Use of ceramides and LPLs in diagnosing CVD
ZORA BIOSCIENCES OY0 citations33
LAAKSONEN REIJO
4 patentsUS9046538B2Jun 2, 2015
Lipidomic biomarkers for atherosclerosis and cardiovascular disease
LAAKSONEN REIJO8 citations78
US9201080B2Dec 1, 2015
Lipidomic biomarkers for identification of high-risk coronary artery disease patients
LAAKSONEN REIJO1 citations60
US9664698B2May 30, 2017
Biomarkers for sensitive detection of statin-induced muscle toxicity
LAAKSONEN REIJO1 citations48
US9541565B2Jan 10, 2017
Biomarkers for sensitive detection of statin-induced muscle toxicity
LAAKSONEN REIJO1 citations48